Colorectal cancer: a model for epigenetic tumorigenesis
Open Access
- 1 January 2007
- Vol. 56 (1) , 140-148
- https://doi.org/10.1136/gut.2005.088799
Abstract
Recent advances in basic and clinical science have driven epigenetics to the forefront of cancer research. Together with genetic changes, the disruption of epigenetic mechanisms is now established as a hallmark of cancer in humans. Colorectal cancer, long a classic model for the genetic basis of cancer, is now providing researchers with the opportunity to view epigenetic events in the context of neoplasia in humans. Knowledge of the heritable changes in gene expression that result from epigenetic events is of increasing relevance to clinical practice, particularly in terms of diagnostic and prognostic molecular markers, as well as novel therapeutic targetsKeywords
This publication has 100 references indexed in Scilit:
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissueInternational Journal of Colorectal Disease, 2003
- DNA methylation, imprinting and cancerEuropean Journal of Human Genetics, 2002
- Translating the Histone CodeScience, 2001
- The Transcriptional Coactivators p300 and CBP Are Histone AcetyltransferasesPublished by Elsevier ,1996
- Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumourNature, 1993
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- DNA methylation and epigenetic defects in carcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1987
- 5-Methylcytosine content of nuclear DNA during chemical hepatocarcinogenesis and in carcinomas which resultBiochemical and Biophysical Research Communications, 1979